Celon Pharma Balance Sheet Health
Financial Health criteria checks 3/6
Celon Pharma has a total shareholder equity of PLN445.6M and total debt of PLN12.8M, which brings its debt-to-equity ratio to 2.9%. Its total assets and total liabilities are PLN569.3M and PLN123.8M respectively.
Key information
2.9%
Debt to equity ratio
zł12.75m
Debt
| Interest coverage ratio | n/a |
| Cash | zł114.54m |
| Equity | zł445.56m |
| Total liabilities | zł123.75m |
| Total assets | zł569.31m |
Recent financial health updates
Celon Pharma (WSE:CLN) Is In A Good Position To Deliver On Growth Plans
Jul 13
We're Interested To See How Celon Pharma (WSE:CLN) Uses Its Cash Hoard To Grow
Nov 04We Think Celon Pharma (WSE:CLN) Can Afford To Drive Business Growth
Aug 04Celon Pharma (WSE:CLN) Seems To Use Debt Quite Sensibly
May 23Celon Pharma (WSE:CLN) Has A Pretty Healthy Balance Sheet
Dec 03Recent updates
Earnings Update: Celon Pharma S.A. (WSE:CLN) Just Reported And Analysts Are Boosting Their Estimates
Sep 24Celon Pharma (WSE:CLN) Is In A Good Position To Deliver On Growth Plans
Jul 13We're Interested To See How Celon Pharma (WSE:CLN) Uses Its Cash Hoard To Grow
Nov 04We Think Celon Pharma (WSE:CLN) Can Afford To Drive Business Growth
Aug 04Celon Pharma (WSE:CLN) Seems To Use Debt Quite Sensibly
May 23Calculating The Intrinsic Value Of Celon Pharma S.A. (WSE:CLN)
Mar 02Celon Pharma S.A. (WSE:CLN) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?
Feb 09
Celon Pharma's (WSE:CLN) Earnings Are Growing But Is There More To The Story?
Jan 20Celon Pharma (WSE:CLN) Shareholders Have Enjoyed A 12% Share Price Gain
Dec 24Celon Pharma (WSE:CLN) Has A Pretty Healthy Balance Sheet
Dec 03Financial Position Analysis
Short Term Liabilities: CLN's short term assets (PLN189.7M) exceed its short term liabilities (PLN86.3M).
Long Term Liabilities: CLN's short term assets (PLN189.7M) exceed its long term liabilities (PLN37.4M).
Debt to Equity History and Analysis
Debt Level: CLN has more cash than its total debt.
Reducing Debt: CLN's debt to equity ratio has increased from 0% to 2.9% over the past 5 years.
Debt Coverage: CLN's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if CLN's interest payments on its debt are well covered by EBIT.